Related Experiment Video

Updated: Jun 17, 2026

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants
11:39

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants

Published on: March 14, 2013

Blood carbon dioxide levels and adverse outcome in neonatal hypoxic-ischemic encephalopathy

Montasser Nadeem1, Deirdre Murray, Geraldine Boylan

  • 1Neonatal Intensive Care Unit, Cork University Maternity Hospital, Cork, Ireland.

American Journal of Perinatology
|December 17, 2009
PubMed

Insights

In term infants with hypoxic-ischemic encephalopathy, carbon dioxide levels (pCO2) were analyzed. Most infants did not maintain normal pCO2, but abnormal levels were not linked to neurodevelopmental outcomes.

Area of Science:

  • Neonatal neurology
  • Pediatric critical care
  • Respiratory physiology

Background:

  • Hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal brain injury.
  • Maintaining appropriate carbon dioxide levels (pCO2) is crucial for cerebral perfusion and outcome in HIE.
  • Limited data exists on pCO2 patterns and their association with neurodevelopmental outcomes in term infants with HIE.

Purpose of the Study:

  • To investigate pCO2 patterns in term infants with HIE during the first 72 hours of life.
  • To determine the relationship between pCO2 levels (normocapnia, hypocapnia, hypercapnia) and neurodevelopmental outcomes at 24 months.

Main Methods:

  • Retrospective analysis of blood gas data from 52 term infants diagnosed with HIE.
  • pCO2 levels were categorized as normocapnia, moderate hypocapnia (<3.3 kPa), severe hypocapnia (<2.6 kPa), and hypercapnia (>6.6 kPa).
  • Neurodevelopmental outcome was assessed at 24 months of age.

Main Results:

  • Normocapnia was observed in 75.5% of samples, but only 6 out of 52 infants maintained normocapnia throughout the 72-hour period.
  • Mean pCO2 values did not significantly differ between infants with normal (5.43 kPa) and abnormal (5.41 kPa) neurodevelopmental outcomes.
  • No significant association was found between moderate hypocapnia (OR=1.84), severe hypocapnia (OR=3.16), or hypercapnia (OR=1.07) and adverse neurodevelopmental outcomes.

Conclusions:

  • The majority of term infants with HIE do not maintain normocapnia during the initial 72 hours of life.
  • Abnormal pCO2 levels, including hypocapnia and hypercapnia, were not significantly associated with adverse neurodevelopmental outcomes at 24 months in this cohort.
  • Further research may be needed to explore other factors influencing neurodevelopmental outcomes in HIE.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Related Concept Videos

Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Carbon Dioxide Transport in the Blood01:19

Carbon Dioxide Transport in the Blood

Carbon dioxide (CO2) transport in the blood is critical to human physiology. On average, our body cells produce around 200 mL of CO2 per minute, precisely the quantity expelled by the lungs. This process involves the transportation of CO2 from the tissue cells to the lungs in three primary forms.
Forms of CO2 Transport
1. Dissolved in plasma: A small percentage (7-10%) of CO2 is transported and dissolved directly in the plasma.
2. Carbaminohemoglobin: Just over 20% of CO2 is chemically bound to...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: